53 related articles for article (PubMed ID: 11460095)
1. Endocrinological and genetic studies in patients with Polycystic Ovary Syndrome (PCOS).
Ghanaati Z; Peters H; Müller S; Ventz M; Pfüller B; Enchshargal ZA; Rohde W; Dörner G
Neuro Endocrinol Lett; 1999; 20(5):323-327. PubMed ID: 11460095
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic effects on sexual brain organization mediated by sex hormones.
Dörner G; Götz F; Rohde W; Plagemann A; Lindner R; Peters H; Ghanaati Z
Neuro Endocrinol Lett; 2001 Dec; 22(6):403-9. PubMed ID: 11781536
[TBL] [Abstract][Full Text] [Related]
3. Gene- and environment-dependent neuroendocrine etiogenesis of homosexuality and transsexualism.
Dörner G; Poppe I; Stahl F; Kölzsch J; Uebelhack R
Exp Clin Endocrinol; 1991; 98(2):141-50. PubMed ID: 1778227
[TBL] [Abstract][Full Text] [Related]
4. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.
Kamel N; Tonyukuk V; Emral R; Corapçioğlu D; Baştemir M; Güllü S
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):115-21. PubMed ID: 15772904
[TBL] [Abstract][Full Text] [Related]
5. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
8. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
[TBL] [Abstract][Full Text] [Related]
9. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
[TBL] [Abstract][Full Text] [Related]
10. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
12. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
[TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
18. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
20. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.
Söderlund D; Canto P; Carranza-Lira S; Méndez JP
Hum Reprod; 2005 Apr; 20(4):965-9. PubMed ID: 15695318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
